NM_000426.4:c.7760C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000426.4(LAMA2):c.7760C>T(p.Ala2587Val) variant causes a missense change. The variant allele was found at a frequency of 0.695 in 1,612,146 control chromosomes in the GnomAD database, including 393,345 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.63 ( 31327 hom., cov: 32)
Exomes 𝑓: 0.70 ( 362018 hom. )
Consequence
LAMA2
NM_000426.4 missense
NM_000426.4 missense
Scores
4
7
6
Clinical Significance
Conservation
PhyloP100: 4.63
Publications
43 publications found
Genes affected
LAMA2 (HGNC:6482): (laminin subunit alpha 2) Laminin, an extracellular protein, is a major component of the basement membrane. It is thought to mediate the attachment, migration, and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. It is composed of three subunits, alpha, beta, and gamma, which are bound to each other by disulfide bonds into a cross-shaped molecule. This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). Mutations in this gene have been identified as the cause of congenital merosin-deficient muscular dystrophy. Two transcript variants encoding different proteins have been found for this gene. [provided by RefSeq, Jul 2008]
LAMA2 Gene-Disease associations (from GenCC):
- congenital merosin-deficient muscular dystrophy 1AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- LAMA2-related muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy, limb-girdle, autosomal recessive 23Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=1.0597179E-5).
BP6
Variant 6-129486484-C-T is Benign according to our data. Variant chr6-129486484-C-T is described in ClinVar as Benign. ClinVar VariationId is 167247.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.714 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LAMA2 | NM_000426.4 | c.7760C>T | p.Ala2587Val | missense_variant | Exon 56 of 65 | ENST00000421865.3 | NP_000417.3 | |
| LAMA2 | NM_001079823.2 | c.7748C>T | p.Ala2583Val | missense_variant | Exon 55 of 64 | NP_001073291.2 | ||
| LOC124901401 | XR_007059767.1 | n.-10G>A | upstream_gene_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.632 AC: 95962AN: 151854Hom.: 31302 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
95962
AN:
151854
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.672 AC: 168513AN: 250778 AF XY: 0.677 show subpopulations
GnomAD2 exomes
AF:
AC:
168513
AN:
250778
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.702 AC: 1024939AN: 1460174Hom.: 362018 Cov.: 43 AF XY: 0.701 AC XY: 509109AN XY: 726458 show subpopulations
GnomAD4 exome
AF:
AC:
1024939
AN:
1460174
Hom.:
Cov.:
43
AF XY:
AC XY:
509109
AN XY:
726458
show subpopulations
African (AFR)
AF:
AC:
14909
AN:
33434
American (AMR)
AF:
AC:
30366
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
AC:
19582
AN:
26118
East Asian (EAS)
AF:
AC:
24890
AN:
39646
South Asian (SAS)
AF:
AC:
56013
AN:
86208
European-Finnish (FIN)
AF:
AC:
34220
AN:
53370
Middle Eastern (MID)
AF:
AC:
4027
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
799642
AN:
1110616
Other (OTH)
AF:
AC:
41290
AN:
60318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
16068
32136
48203
64271
80339
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
19858
39716
59574
79432
99290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.632 AC: 96029AN: 151972Hom.: 31327 Cov.: 32 AF XY: 0.630 AC XY: 46794AN XY: 74256 show subpopulations
GnomAD4 genome
AF:
AC:
96029
AN:
151972
Hom.:
Cov.:
32
AF XY:
AC XY:
46794
AN XY:
74256
show subpopulations
African (AFR)
AF:
AC:
18821
AN:
41430
American (AMR)
AF:
AC:
10235
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
2558
AN:
3470
East Asian (EAS)
AF:
AC:
3250
AN:
5168
South Asian (SAS)
AF:
AC:
2977
AN:
4816
European-Finnish (FIN)
AF:
AC:
6924
AN:
10536
Middle Eastern (MID)
AF:
AC:
209
AN:
294
European-Non Finnish (NFE)
AF:
AC:
48911
AN:
67960
Other (OTH)
AF:
AC:
1389
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1725
3451
5176
6902
8627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
784
1568
2352
3136
3920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2648
ALSPAC
AF:
AC:
2791
ESP6500AA
AF:
AC:
2058
ESP6500EA
AF:
AC:
6248
ExAC
AF:
AC:
81020
Asia WGS
AF:
AC:
2208
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Dec 03, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Jan 20, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Merosin deficient congenital muscular dystrophy Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
LAMA2-related muscular dystrophy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
.;T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;.;M
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;.;D
REVEL
Uncertain
Sift
Benign
.;.;T
Polyphen
1.0
.;.;D
Vest4
MPC
0.45
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.